LXEO R&D Expense Growth

Lexeo Therapeutics Inc · R&D Expense Growth

LXEO logo

LXEO R&D Expense Growth

Latest reported-13.89%
LXEO FY R&D Growth (YoY) (0.00% → -13.89%)
High-resolution chart · PNG

LXEO r&d expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Lexeo Therapeutics Inc R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
-13.8937%
39.4523%
8.0713%
8.9559%
944.7663%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.